Remyelination therapies: a new direction and challenge in multiple sclerosis

Nature Reviews Drug Discovery 16, 617 (2017). doi:10.1038/nrd.2017.115 Authors: Jason R. Plemel, Wei-Qiao Liu & V. Wee Yong Multiple sclerosis is characterized by inflammatory activity that results in destruction of the myelin sheaths that enwrap axons. The currently available medications for multiple sclerosis are predominantly immune-modulating and do not directly promote repair. White matter regeneration, or remyelination, is a new and exciting potential
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Review Source Type: research